Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
55.53 USD | +0.78% | +6.12% | +7.33% |
Mar. 20 | Sector Update: Health Care Stocks Ease Late Afternoon | MT |
Mar. 20 | Sector Update: Health Care Stocks Down Wednesday Afternoon | MT |
Financials (USD)
Sales 2024 * | 1.21B | Sales 2025 * | 1.27B | Capitalization | 3B |
---|---|---|---|---|---|
Net income 2024 * | 57M | Net income 2025 * | 197M | EV / Sales 2024 * | 2.39 x |
Net cash position 2024 * | 102M | Net cash position 2025 * | 231M | EV / Sales 2025 * | 2.18 x |
P/E ratio 2024 * |
46
x | P/E ratio 2025 * |
33.3
x | Employees | 2,900 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 99.44% |
Latest transcript on LivaNova PLC
1 day | +0.78% | ||
1 week | +6.12% | ||
Current month | -0.73% | ||
1 month | +2.10% | ||
3 months | +12.09% | ||
6 months | +17.85% | ||
Current year | +7.33% |
Managers | Title | Age | Since |
---|---|---|---|
Alex Shvartsburg
DFI | Director of Finance/CFO | 54 | 16-12-31 |
William Kozy
CHM | Chairman | 72 | 18-06-11 |
Matt J. Dodds
CTO | Chief Tech/Sci/R&D Officer | - | 18-01-07 |
Members of the board | Title | Age | Since |
---|---|---|---|
Director/Board Member | 63 | 20-12-02 | |
Peter Wilver
BRD | Director/Board Member | 64 | 22-06-12 |
William Kozy
CHM | Chairman | 72 | 18-06-11 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.19% | 509 M€ | -.--% |
Date | Price | Change | Volume |
---|---|---|---|
24-04-26 | 55.53 | +0.78% | 553,327 |
24-04-25 | 55.1 | -1.50% | 536,705 |
24-04-24 | 55.94 | +1.67% | 977,319 |
24-04-23 | 55.02 | +1.87% | 661,198 |
24-04-22 | 54.01 | +3.21% | 733,740 |
Delayed Quote Nasdaq, April 26, 2024 at 04:00 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+7.33% | 3B | |
-2.31% | 187B | |
-3.20% | 106B | |
-5.04% | 66.9B | |
+0.20% | 49.45B | |
+17.29% | 48B | |
+4.06% | 40.84B | |
+2.36% | 26.25B | |
+2.07% | 26.48B | |
+12.96% | 24.62B |
- Stock Market
- Equities
- LIVN Stock